Ceftibuten-ledaborbactam etzadroxil
Phase 1Small molecule
Basilea PharmaceuticaCeftibuten-ledaborbactam etzadroxil is one of 5 small molecule programs targeting FDC. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
4 competitors in FDC
#DrugCompanyPhaseTrials
1Nexium
DDexcel Pharma Technologies Ltd.
Phase 1
Amoxicillin-Clavulanate
IIterum Therapeutics, International Limited
Phase 1
Cedax
BBurke Medical Research Institute
Phase 1
Ceftibuten-ledaborbactam etzadroxil
Basilea PharmaceuticaPhase 1
Ledaborbactam Etzadroxil
Basilea PharmaceuticaPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
FDC1 trial
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company